Immunotherapy plus chemotherapy versus chemotherapy alone in the first-line treatment for advanced gastric cancer/gastroesophageal junction cancer: a real-world retrospective study
Compared with chemotherapy alone, first-line ICIs combined with chemotherapy in patients with advanced GC/GEJC could greatly prolong PFS, but OS was not significantly improved, and the AEs were manageable.
Authors
- Caiyan Jia
- Yingjie Jia
- Qian Xu (ORCID: https://orcid.org/0000-0002-9267-906X)
- Fanming Kong (ORCID: https://orcid.org/0000-0003-1959-8551)
- Dan Yi (ORCID: https://orcid.org/0000-0002-2626-3517)
Institutions
- Tianjin University of Traditional Chinese Medicine (CN)
- First Teaching Hospital of Tianjin University of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2024-11-07
- DOI
- https://doi.org/10.3389/fimmu.2024.1463017
- Citations
- 6
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 2.51